Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial

JAMA

Volumn 299, Issue 16, 2008, Pages 1914-1921

  Ajani, Jaffer A ^a   Winter, Kathryn A ^b   Gunderson, Leonard L ^c   Pedersen, John ^d   Benson III, Al B ^e   Thomas, Charles R ^f   Mayer, Robert J ^g   Haddock, Michael G ^h   Rich, Tyvin A ⁱ   Willett, Christopher ^j  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c MAYO CLINIC   (United States)

^d CROSS CANCER INSTITUTE   (Canada)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF OREGON   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j DUKE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ALLERGY; ANUS CARCINOMA; ARTICLE; BLADDER DISEASE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLOSTOMY; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; ENDOCRINE DISEASE; EYE TOXICITY; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HUMAN; INFECTION; LIVER TOXICITY; LUNG TOXICITY; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OTOTOXICITY; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTOSCOPY; SEXUAL FUNCTION; SIDE EFFECT; SIGMOIDOSCOPY; SKIN TOXICITY; STOMATITIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING; ANUS TUMOR; COMPARATIVE STUDY; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE FRACTIONATION; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS;

EID: 42449128805     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.16.1914     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer. 1983;51(10):1826-1829.
3. Klotz RG, Pamukgoglu T, Souliard DH. Transistional cloacogenic carcinoma of the anal canal: clinicopathologic study of three hundred seventy-three cases. Cancer. 1967;20(10):1727-1745.
4. Greenall MJ, Quan SH, Urmacher C, et al. Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet. 1985;161(6):509-517.
5. Boman BM, Moertel CG, O'Connell MJ, et al. Carcinoma of the of the anal canal: a clinical and pathologic study of 188 cases. Cancer. 1984;54(1):114-125.
6. Sato H, Koh PK, Bartolo DC. Management of anal canal cancer. Dis Colon Rectum. 2005;48(6):1301-1315.
7. Frost DB, Richards PD, Montague ED, et al. Epidermoid cancer of the anorectum. Cancer. 1984;53(6):1285-1293.
8. Schneider TC, Schulte WJ. Management of carcinoma of the anal canal. Surgery. 1981;90(4):729-734.
9. Singh R, Nime F, Mittelman A. Malignant epithelial tumors of the anal canal. Cancer. 1981;48(2):411-415.
10. Fuchshuber PR, Rodriguez-Bigas M, Petrelli NJ. Anal canal and perianal epidermoid cancer. J Am Coll Surg. 1997;185(5):494-505.
11. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal: a series of 276 cases. Dis Colon Rectum. 1987;30(5):324-333.
12. Pintor MP, Northover JMA, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984 Br J Surg. 1989;76(8):806-810.
13. Allal AS, Laurencet FM, Reymond MA, et al. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter conserving treatment. Cancer. 1999;86(3):405-409.
14. UK Co-ordinating Committee on Cancer Research Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348(9034):1049-1054.
15. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15(5):2040-2049.
16. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized Intergroup study. J Clin Oncol. 1996;14(9):2527- 2539.
17. John M, Flam M, Berkey B, et al. Proceedings of the American Society of Clinical Oncology 5-Year results and analyses of a phase III randomized RTOG /ECOG chemoradiation protocol for anal cancer. Alexandria, VA: American Society of Clinical Oncology; 1998. Abstract 989.
18. Rich TA, Ajani JA, Morrison WH, et al. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of fluorouracil with or without cisplatin. Radiother Oncol. 1993;27(3):209-215.
19. Gerard JP, Ayzac L, Hun D, et al. Treatment of anal carcinoma with high-dose radiation and concomitant fluorouracil-cisplatin: long-term results in 95 patients. Radiother Oncol. 1998;46(3):249-256.
20. Martenson JA, Lipsitz SR, Wagner H Jr, et al. Initial results of a phase II trial of high-does radiation therapy, fluorouracil and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Group study. Int J Radiat Oncol Biol Phys. 1996;35(4):745-749.
21. Doci R, Zucali R, Bombelli L, et al. Combined chemoradiation therapy for anal cancer: a report of 56 cases. Ann Surg. 1992;215(2):150-156.
22. Peiffert D, Giovannini M, Ducreux M, et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal carcinoma: final results of a phase II study. Ann Oncol. 2001;12(3):397-404.
23. Meropol NJ, Niedzwiecki D, Shank B, et al. Proceedings of the ASCO Gastrointestinal Symposium. Combined-modality therapy of poor prognosis anal canal carcinoma: a phase II study of Cancer and Leukemia Group B (CALGB). In: Alexandria, VA: American Society of Clinical Oncology; 2005. Abstract 238.
24. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis. 1994;27:365-375.
25. National Cancer Institute. Common Toxicity Criteria Version 2.0. June 1, 1999. http://ctep.cancer.gov/forms. Accessed March 18, 2008.
26. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-1346.
27. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549-556.
28. East, a Software Package for the Design and Interim Monitoring of Group Sequential Clinical Trials [software manual]. Cambridge, MA: Cytel Software Corp; 1992.
29. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
30. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163-170.
31. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
32. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist. 1988;16:1141-1154.
33. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook, Sixth Edition. New York, NY: Springer-Verlag; 2002.
34. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567-578.